Consistent with findings reported by Wang and colleagues showing that MELK is most highly overexpressed in TNBC (17), our analysis of tumor tissues from 314 patients with breast cancer showed that MELK mRNA expression was significantly higher in patients with TNBC than in patients with the HR+HER2− subtype. This evidence concerns the gene ERBB2 and neoplasm.